Stephen Baxter
Stock Analyst at Wells Fargo
(3.26)
# 1,205
Out of 5,111 analysts
231
Total ratings
49.67%
Success rate
1.38%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PNTG The Pennant Group | Upgrades: Overweight | $29 → $31 | $29.74 | +4.24% | 3 | Nov 18, 2025 | |
| OSCR Oscar Health | Maintains: Underweight | $14 → $11 | $15.66 | -29.73% | 13 | Nov 13, 2025 | |
| CVS CVS Health | Maintains: Overweight | $103 → $102 | $77.32 | +31.92% | 16 | Nov 13, 2025 | |
| UHS Universal Health Services | Maintains: Overweight | $249 → $259 | $222.29 | +16.51% | 16 | Nov 13, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $238 → $252 | $195.24 | +29.07% | 16 | Nov 13, 2025 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $412 → $431 | $464.32 | -7.18% | 17 | Nov 13, 2025 | |
| MOH Molina Healthcare | Maintains: Overweight | $231 → $165 | $161.45 | +2.20% | 21 | Nov 12, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $41 → $35 | $38.58 | -9.28% | 24 | Nov 12, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $33 → $39 | $36.46 | +6.97% | 7 | Nov 12, 2025 | |
| COR Cencora | Maintains: Overweight | $354 → $405 | $340.89 | +18.81% | 5 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $816 → $914 | $803.26 | +13.79% | 9 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1.5 → $1 | $0.68 | +48.04% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $354 → $300 | $275.98 | +8.70% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $185 → $221 | $197.48 | +11.91% | 9 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $412 → $403 | $347.67 | +15.91% | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $267 → $400 | $333.24 | +20.03% | 15 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $344 → $347 | $261.72 | +32.58% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2.5 → $3 | $3.26 | -7.98% | 11 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $7.54 | +98.94% | 3 | Apr 29, 2024 |
The Pennant Group
Nov 18, 2025
Upgrades: Overweight
Price Target: $29 → $31
Current: $29.74
Upside: +4.24%
Oscar Health
Nov 13, 2025
Maintains: Underweight
Price Target: $14 → $11
Current: $15.66
Upside: -29.73%
CVS Health
Nov 13, 2025
Maintains: Overweight
Price Target: $103 → $102
Current: $77.32
Upside: +31.92%
Universal Health Services
Nov 13, 2025
Maintains: Overweight
Price Target: $249 → $259
Current: $222.29
Upside: +16.51%
Tenet Healthcare
Nov 13, 2025
Maintains: Overweight
Price Target: $238 → $252
Current: $195.24
Upside: +29.07%
HCA Healthcare
Nov 13, 2025
Maintains: Equal-Weight
Price Target: $412 → $431
Current: $464.32
Upside: -7.18%
Molina Healthcare
Nov 12, 2025
Maintains: Overweight
Price Target: $231 → $165
Current: $161.45
Upside: +2.20%
Centene
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $41 → $35
Current: $38.58
Upside: -9.28%
BrightSpring Health Services
Nov 12, 2025
Maintains: Overweight
Price Target: $33 → $39
Current: $36.46
Upside: +6.97%
Cencora
Nov 11, 2025
Maintains: Overweight
Price Target: $354 → $405
Current: $340.89
Upside: +18.81%
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $816 → $914
Current: $803.26
Upside: +13.79%
Nov 5, 2025
Maintains: Overweight
Price Target: $1.5 → $1
Current: $0.68
Upside: +48.04%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $354 → $300
Current: $275.98
Upside: +8.70%
Nov 5, 2025
Maintains: Overweight
Price Target: $185 → $221
Current: $197.48
Upside: +11.91%
Oct 22, 2025
Maintains: Overweight
Price Target: $412 → $403
Current: $347.67
Upside: +15.91%
Oct 7, 2025
Maintains: Overweight
Price Target: $267 → $400
Current: $333.24
Upside: +20.03%
Oct 7, 2025
Maintains: Overweight
Price Target: $344 → $347
Current: $261.72
Upside: +32.58%
Oct 7, 2025
Maintains: Underweight
Price Target: $2.5 → $3
Current: $3.26
Upside: -7.98%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $7.54
Upside: +98.94%